Design of cross-over trials for pharmacokinetic studies
DOI10.1016/S0378-3758(98)00221-3zbMATH Open0933.62113OpenAlexW2078186230WikidataQ127323757 ScholiaQ127323757MaRDI QIDQ1300941FDOQ1300941
Authors: V. Pereyra 
Publication date: 2 April 2000
Published in: Journal of Statistical Planning and Inference (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/s0378-3758(98)00221-3
Recommendations
- Optimal cross-over designs for nonlinear mixed models using a first-order expansion
- Optimal parametric design with applications to pharmacokinetic and pharmacodynamic trials
- Optimal crossover designs for generalized linear models
- Optimal designs for random effect models with correlated errors with applications in population pharmacokinetics
- Optimal cross-over designs for full interaction models
Applications of statistics to biology and medical sciences; meta analysis (62P10) Optimal statistical designs (62K05) Kinetics in biochemical problems (pharmacokinetics, enzyme kinetics, etc.) (92C45)
Cites Work
- Bayesian experimental design: A review
- The Equivalence of Two Extremum Problems
- Optimum Experimental Designs for Properties of a Compartmental Model
- Title not available (Why is that?)
- Recent Advances in Nonlinear Experimental Design
- An extension of the General Equivalence Theorem to nonlinear models
- Information matrices for mixed effects models with applications to the optimality of repeated measurements designs
- Title not available (Why is that?)
- Recent Developments in the Methods of Optimum and Related Experimental Designs
Cited In (5)
- Optimal cross-over designs for nonlinear mixed models using a first-order expansion
- Optimal parametric design with applications to pharmacokinetic and pharmacodynamic trials
- Evaluation of the Fisher information matrix in nonlinear mixed effect models using adaptive Gaussian quadrature
- Optimal designs for nonlinear regression models with respect to non-informative priors
- Further Developments of the Fisher Information Matrix in Nonlinear Mixed Effects Models with Evaluation in Population Pharmacokinetics
This page was built for publication: Design of cross-over trials for pharmacokinetic studies
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q1300941)
